Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CAnadian Normoglycemia Outcomes Evaluation Study

NCT00116922 is registered in ClinicalTrials.gov with Samuel Lunenfeld Research Institute, Mount Sinai Hospital as lead sponsor.

NCT NCT00116922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00116922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CAnadian Normoglycemia Outcomes Evaluation Study
Lead sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2004
Completion date
January 31, 2010
Enrollment
207 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, impaired glucose tolerance